Navigation Links
NEBA Health Releases Key Study Results for the first FDA approved brain wave test to help clinicians assess ADHD in children and adolescents
Date:7/22/2013

AUGUSTA, Ga., July 22, 2013 /PRNewswire/ -- NEBA Health, LLC releases today key study results regarding the FDA approval of NEBA®, the first brain wave test to help clinicians assess ADHD in children and adolescents.  FDA cleared NEBA for marketing on July 15, 2013.

About NEBA
NEBA integrates an ADHD biomarker together with a clinician's ADHD evaluation. In other words, NEBA is not used as a stand-alone diagnostic. The clinician still conducts their ADHD evaluation as in their regular practice using their usual assessment tools. Once the clinician determines that ADHD-like symptoms are present, NEBA helps the clinician to determine whether the symptoms are due to ADHD, or due to another condition. NEBA does this using EEG to separate ADHD patients into biomarker-based groups with clinical differences that allow validated recommendations to be offered to the clinicians.

Because ADHD symptoms overlap with other diagnoses, there may be difficulty for the clinician to determine whether ADHD is the primary cause, whether ADHD symptoms are secondary to other diagnoses, or whether ADHD is comorbid with other diagnoses. Dr. Steve Snyder, Vice President of Research and Development said, "NEBA can help the clinician to confirm ADHD as primary diagnosis, and can help the clinician to determine whether ADHD-like symptoms may be better explained by another primary condition."

About NEBA accuracy
Previous studies have supported that a multidisciplinary team of clinicians is better able than an individual clinician to determine if ADHD-like symptoms are due to another primary condition. Similarly in the NEBA Clinical Investigation reviewed by the FDA, a triple-blinded protocol showed only 61% agreement between individual clinicians and a multidisciplinary team. The investigation also showed that a clinician could use NEBA to improve accuracy from 61% to 88%.  (Study results are posted at http://www.nebahealth.com/results.htm)

Dr. Snyder said, "Our study supports that a clinician using NEBA as one part of a full ADHD evaluation would be more likely to converge upon diagnostic evaluation results of a multidisciplinary team."

About NEBA costs
Using NEBA will lead to cost savings. Dr. Snyder said, "Whereas NEBA adds some upfront costs, it does reduce overall costs in the long term by significantly reducing misdiagnosis." NIH/HHS awarded the company a Qualifying Therapeutic Discovery Project grant in October of 2010 based in part on NEBA's potential to be cost saving.

Howard Merry, President, said, "Introducing NEBA in the United States is the culmination of seven years of dedicated work with FDA and follows our CE marking in Europe and Health Canada licensing. Our small team has been together for the entire duration of this project and we are committed to helping clinicians, children, and families."

About NEBA Health
NEBA Health is focused on Neuropsychiatric Interpretive EEG Assessment Aids. We have ongoing work in ADHD, depression and dementia. Our first product - eponymously named NEBA - is an ADHD assessment aid cleared for marketing in the USA (K112711), as well as CE marked and Health Canada licensed.


'/>"/>
SOURCE NEBA Health, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
2. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
3. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
4. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
5. inVentiv Health Selected to Provide Sales Operations Support for Santarus
6. Masimo to Present at 23rd Annual Piper Jaffray Health Care Conference
7. Hong Kong Department of Health to Combat Sudden Cardiac Arrest With Powerheart AEDs
8. Nations Best Health Care Organizations for Patient Satisfaction, Core Measures Honored by Press Ganey
9. Sequenom Announces Participation at the 23rd Annual Piper Jaffray Healthcare Conference
10. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
11. Health Diagnostic Laboratory, Inc. Provides Largest Corporate Gift in Science Museum of Virginias History
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... They call ... complex biological network, a depiction of a system of linkages and connections so ... PhD, associate professor of computer science at Worcester Polytechnic Institute (WPI) and director ...
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS announces expanded ... of its newest module, US Hemostats & Sealants. , SmartTRAK’s US Market for ... fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. BioMedGPS estimates ...
(Date:10/11/2017)... LINDA, CA (PRWEB) , ... October 11, 2017 ... ... to upregulate any gene in its endogenous context, enabling overexpression experiments and avoiding ... (CRISPRa) system with small RNA guides is transformative for performing systematic gain-of-function studies. ...
(Date:10/11/2017)... , Oct. 11, 2017  VMS BioMarketing, a leading provider ... nationwide oncology Clinical Nurse Educator (CNE) network, which will launch ... for communication among health care professionals to enhance the patient ... office staff, and other health care professionals to help women ... cancer. ...
Breaking Biology Technology:
(Date:4/5/2017)... 5, 2017  The Allen Institute for Cell Science ... a one-of-a-kind portal and dynamic digital window into the ... the first application of deep learning to create predictive ... lines and a growing suite of powerful tools. The ... and future publicly available resources created and shared by ...
(Date:3/30/2017)... March 30, 2017  On April 6-7, 2017, Sequencing.com ... Genome hackathon at Microsoft,s headquarters in ... will focus on developing health and wellness apps that ... Hack the Genome is the first hackathon for ... world,s largest companies in the genomics, tech and health ...
(Date:3/27/2017)... CENTRE, N.Y. , March 27, 2017 /PRNewswire-USNewswire/ ... Healthcare Information and Management Systems Society (HIMSS) Analytics ... Outpatient EMR Adoption Model sm . In addition, ... 12% of U.S. hospitals using an electronic medical ... CHS for its high level of EMR usage ...
Breaking Biology News(10 mins):